Xcelience boosts solid oral dosage form capabilities

Contract research manufacturer Xcelience has expanded its solid oral dosage form capabilities by adding a Vector TFC-220 roller compactor. The new gear aids drug developers in the transition to GMP production of clinical supplies. Xcelience last March announced its alliance with three other contractors to provide a project management service that streamlines hand-offs between drugmakers and contractors throughout the various stages of drug development. Xcelience release

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.